(RMDs) and at optimising the use of nursing competencies [1]. In the Netherlands, these recommendations seem well implemented. There are specialised nurses (SNs); nurses trained at a secondary vocational or Bachelor level, followed by a one-year educational program in rheumatology, and nurse practitioners (NPs), trained on a Master Level. SNs provide information, education and (psychosocial) support, but also monitoring of disease, supervised by a rheumatologist. NPs are trained and legally authorised to provide integral medical (e.g. prescribing) and nursing care independently. Informal discussions among rheumatology nurses suggest a variation in roles, and tasks of SNs and NPs, and of care organisation in rheumatology practices. Objectives: The objective of this study was to explore current roles and tasks of SNs and NPs, and care organisation in order to visualise potential variation. Methods: A web-based questionnaire, based on literature [2] and existing task descriptions was disseminated among all members of the Dutch Nurses Association, unit Rheumatology (n=257). The questions were in closed-ended, multiple choice, likert-scales and open-ended format as appropriate. Data were analysed descriptively. Subgroup analyses were carried out for SNs and NPs. Results: In total 84 nurses, 75 SNs and 9 NPs responded. Characteristics, roles and main tasks are presented in Table 1 .The majority of the SNs, 96.4%, and 100% of the NPs work at the outpatient clinic, providing individual face-to-face consultations or telephone support. Conclusions: Differences in roles, tasks and available time for consultations visualise variation in care organisation and in the content of rheumatology nursing care, also within the SN and NP group respectively. Further research on these differences is necessary but they show inequity of care for people with RMDs in the Netherlands and also suggests suboptimal use of nursing competencies. To what extent these factors affect the health related quality of life (HRQL) of these patients is largely unexplored. Disease activity scores for PSS have been developed but there is no disease-specific HRQL questionnaire available so far. Objectives: To develop a questionnaire for the assessment of HRQL in PSS. Methods: In a previous qualitative study, concepts related to HRQL in PSS were identified by focus-group interviews with PSS patients. Based on these concepts, a questionnaire (PSS-QoL) was developed focusing on two main topics: physical (pain and dryness) and psychosocial dimension. The first draft of this questionnaire was evaluated by semi-structured interviews with PSS patients (n=6) and rheumatologists (n=4). Based on their feedback, a revised questionnaire was constructed and re-evaluated by the patients and physicians. Subsequently, psychometric testing of PSS-QoL was performed in 75 PSS patients of the outpatient clinic of the Medical University Graz. For testing of internal consistency Crohnbach's α was used. Convergent construct validity was tested by correlating the scores with the ESSPRI and the EQ-5D. Reliability was examined by asking patients who considered themselves to be in a stable disease to complete the questionnaire 1-2 weeks apart. In addition, an English version of PSS-QoL was was developed using a standard methodology for translation. Results: Out of the 75 PSS patients, 91% were female, disease duration was 4.8±4.08 years and age of patients was 58.5±12.5 years.The internal consistency of the PSS-QoL showed a Crohnbach's α of 0.892 and we found a moderate correlation of the PSS-QoL with the ESSPRI (Corr coeff =0.625) and the EQ-5D (EQ5D-pain/discomfort; corr coeff =0.531). A second assessment was performed after 1-2 weeks in 21 patients with stable disease. The ICC for PSS-QoL was 0.958 (95% CI 0.926 to 0.981). In comparison, the ICC for EQ-5D in this population was 0.854 (95% CI 0.735 to 0.933). Subsequently, the final German version of PSS-QoL was translated forward and back into English by native speakers. Conclusions: A questionnaire to assess the HRQL in PSS patients has been developed and tested for its psychometric properties. The PSS-QoL should allow for a better and more comprehensive assessment on patients' HRQL in PSS. Background: The educational needs of people with undifferentiated spondyloarthritis (USpA) have not been well studied. The educational needs assessment tool (ENAT) has been translated into Swedish and validated in other rheumatic diseases but not USpA.
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PSYCHOMETRIC TESTING OF A NEW PATIENT-REPORTED OUTCOME MEASURE FOR PSS PATIENTS
To what extent these factors affect the health related quality of life (HRQL) of these patients is largely unexplored. Disease activity scores for PSS have been developed but there is no disease-specific HRQL questionnaire available so far. Objectives: To develop a questionnaire for the assessment of HRQL in PSS. Methods: In a previous qualitative study, concepts related to HRQL in PSS were identified by focus-group interviews with PSS patients. Based on these concepts, a questionnaire (PSS-QoL) was developed focusing on two main topics: physical (pain and dryness) and psychosocial dimension. The first draft of this questionnaire was evaluated by semi-structured interviews with PSS patients (n=6) and rheumatologists (n=4). Based on their feedback, a revised questionnaire was constructed and re-evaluated by the patients and physicians. Subsequently, psychometric testing of PSS-QoL was performed in 75 PSS patients of the outpatient clinic of the Medical University Graz. For testing of internal consistency Crohnbach's α was used. Convergent construct validity was tested by correlating the scores with the ESSPRI and the EQ-5D. Reliability was examined by asking patients who considered themselves to be in a stable disease to complete the questionnaire 1-2 weeks apart. In addition, an English version of PSS-QoL was was developed using a standard methodology for translation. Results: Out of the 75 PSS patients, 91% were female, disease duration was 4.8±4.08 years and age of patients was 58.5±12.5 years.The internal consistency of the PSS-QoL showed a Crohnbach's α of 0.892 and we found a moderate correlation of the PSS-QoL with the ESSPRI (Corr coeff =0.625) and the EQ-5D (EQ5D-pain/discomfort; corr coeff =0.531). A second assessment was performed after 1-2 weeks in 21 patients with stable disease. The ICC for PSS-QoL was 0.958 (95% CI 0.926 to 0.981). In comparison, the ICC for EQ-5D in this population was 0.854 (95% CI 0.735 to 0.933). Subsequently, the final German version of PSS-QoL was translated forward and back into English by native speakers. Conclusions: A questionnaire to assess the HRQL in PSS patients has been developed and tested for its psychometric properties. The PSS-QoL should allow for a better and more comprehensive assessment on patients' HRQL in PSS. Multicentre studies for further validation are needed. Disclosure of Interest: None declared DOI: 10.1136/annrheumdis-2017-eular.3372
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1 Objectives: To validate the educational needs assessment tool (ENAT) in people with USpA and use it to study their educational needs. Methods: A cross-sectional study recruiting a random sample of patients with USpA from a hospital register. USpA was diagnosed according to the International Classification of Disease, ICD-10 (M46.0, M46.1, M46.8, and M46.9).
1 The study was approved by the Regional Ethics Board and all included patients signed an informed consent. We used a postal survey to collect data on disease activity (BASDAI) and educational needs (Swedish version of the ENAT).
2 The data was then utilized to assess the construct validity, internal consistency, unidimensionality and response bias of the ENAT using Rash analysis. Given fit to the Rasch model, we transformed the ENAT ordinal scores into interval logitbased scores before deploying descriptive and inferential statistics. Total ENAT Score ranges between 0 (no needs) and 156 (the highest level of needs), and comprises seven subscales (pain 0-24, movement 0-20, feelings 0-16, disease 0-28, treatments 0-28, self-help 0-24 and support 0-16). Finally, we categorised the data by gender, age (median split) and disease activity (BASDAI split at 4) and assessed differences between patient subgroups using the student's t-test. Results: Complete responses were derived from 77 patients (48 women), mean (SD) age 50 (12) years, disease duration was 16 (11) years, BASDAI 4.9 (1.9) and BASFI 3.1 (2.3). When used as a 7-subscale questionnaire, the ENAT satisfied the requirements of Rasch model (c 2 =11.488; p=0.119) including strict unidimensionality. Overall, the mean (SD) ENAT scores for patients with USpA was 86 (32). Women reported higher needs than men in the domains of pain, mean (SD) 13.1 (6.8) vs. 10.1 (6.0), p=0.05; movement mean (SD) 13.0 (5.5) vs. 9.9 (5.7), p=0.02 and self-help, mean (SD) 17.0 (5.8) vs. 14.1 (5.0), p=0.03). Higher disease activity (BASDAI >4) was associated with higher educational needs, mean (SD) 92.6 (31.9) vs. 73.7 (29.4), p=0.02. There was no significant difference in educational needs between age groups. Conclusions: The Swedish ENAT has been validated in USpA thus enabling an accurate estimation of the educational needs of people with USpA in Sweden.
